Table of Content

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in metabolic dealmaking



2.1. Introduction

2.2. Metabolic partnering over the years

2.3. Metabolic partnering by deal type

2.4. Metabolic partnering by industry sector

2.5. Metabolic partnering by stage of development

2.6. Metabolic partnering by technology type

2.7. Metabolic partnering by therapeutic indication



Chapter 3 – Financial deal terms for metabolic partnering



3.1. Introduction

3.2. Disclosed financials terms for metabolic partnering

3.3. Metabolic partnering headline values

3.4. Metabolic deal upfront payments

3.5. Metabolic deal milestone payments

3.6. Metabolic royalty rates



Chapter 4 – Leading metabolic deals and dealmakers



4.1. Introduction

4.2. Most active in metabolic partnering

4.3. List of most active dealmakers in metabolic

4.4. Top metabolic deals by value



Chapter 5 – Metabolic contract document directory



5.1. Introduction

5.2. Metabolic partnering deals where contract document available



Chapter 6 – Metabolic dealmaking by therapeutic target



6.1. Introduction

6.2. Deals by metabolic therapeutic target



Deal directory



Deal directory – Metabolic deals by company A-Z 2016 to 2023

Deal directory – Metabolic deals by technology type 2016 to 2023



Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from CurrentPartnering



Table of figures



Figure 1: Metabolic partnering since 2016

Figure 2: Metabolic partnering by deal type since 2016

Figure 3: Metabolic partnering by industry sector since 2016

Figure 4: Metabolic partnering by stage of development since 2016

Figure 5: Metabolic partnering by technology type since 2016

Figure 6: Metabolic partnering by indication since 2016

Figure 7: Metabolic deals with a headline value

Figure 8: Metabolic deals with upfront payment values

Figure 9: Metabolic deals with milestone payment

Figure 10: Metabolic deals with royalty rates

Figure 11: Active metabolic dealmaking activity since 2016

Figure 12: Top metabolic deals by value since 2016